Dr Prashant Mishra Profile picture
Jul 13, 2020 26 tweets 5 min read Read on X
# HESTER BIOSCIENCES LTD
CMP is 1240 , MCAP 1050 Cr , Promoters holding around 54% , Good growth till Fy 19 , FY 19-20 was weak ,Dividend paying company ,BV 236 , Small equity
Started business in 1987 as a trading company, now second largest poultry vaccine manufacturer in India ( largest is venkys ) with two manufacturing unit in Ahmedabad and Nepal . Diagnostic lab - Anand , Hyderabad
Company operates through 4 verticals
1-Poultry vaccines
2-Animal vaccines
3-Poultry health products
4- Animal health products

Company is having around 50 vaccines and 35 health products
Revenue distribution- 76% revenue from poultry 21% from animals
and 3% others .

Poultry division- 14 live vaccine, 32 Inactivated vaccine
Anti infective medicines
Food supplements
Disinfectant for farms and equipment’s sanitizer
Animal health division- 3 active vaccine
Drugs- anti infective, pain killer,
Feed supplements
Disinfectants
Subsidiary
1-Hester Bio Nepal -65% stake of Hester
2-Texas life Sciences- 54.80% stake ( manufacturing and supplying formulation, tablet , capsules , powder for human and veterinary market )
3- Hester Africa -100.% subsidiary ( Tanzania) for veterinary vaccines and animal health products
which will start commercial production by end of 2020
4- Hester Kenya -100% subsidiary-trading business
5-Hester bioscience Tanzania-Trading business
Company started product diversity by focusing on large animal vaccines and because of which poultry health care division revenue contribution is coming down from 84% to 74% as a part of their strategy.
Last year FY 20 was below expectation because of recession in poultry industries because of high maize price(in poultry industry 75% budget goes to feed cost and 50% feed cost is from maize ) and q4 was bad due to covid and company hired more people for new territory, investment.
R&D Pipeline-
1Poultry-development of diagnostic kit
2-Thermotolerant ppr vaccines (thermotolerance–the ability of a vaccine to retain its potency following storage at temperatures in excess of the cold-chain )
3-PPR Nasal spray vaccine.
4-Covid vaccine .
Why poultry health is important
Poultry products contain variable but moderate energy content, highly digestible proteins (with low levels of collagen) of good nutritional quality, unsaturated lipids ,B-group vitamins
mainly thiamin, vitamin B6, and pantothenic acid), and minerals (like iron, zinc, and copper) make poultry meat a valuable food. Poultry vaccines are widely applied to prevent and control contagious poultry diseases and increase production.
Growth drivers
Rising global demand for animal protein
• Increasing trend of Zoonotic diseases to drive demand for vaccines
• Natural resources constraints driving need for more efficient food production
• Livestock rearing is a prominent source of income in some economies
• Increased pet ownership and spending
• Higher focus on food safety and food security
Why I am bullish on Hester
1-Government announced National Animal Disease Control Programme to cover around 53 crore animals, of which 1.5 crore cows and buffaloes have already been vaccinated.(Aim is to increase milk production)
According to estimates, India has 14.6crore female cows (total 19.3 crore male and female), 10 crore female buffaloes (total 11 crore male and female), 7.4 crore sheep, 14.9 crore goat and 90 lakh swine and they have to be vaccinated.
The main animal vaccines are Peste des petits ruminants (PPR) vaccines to protect against viral goat plague, Brucella vaccine to protect against Brucellosis and FMD vaccine to protect against Foot and mouth disease (FMD).
Hester manufacture Brucella and PPR vaccine, Brucella vaccines tender size is around 100 Cr this yr and apart from Hester Indian Immunologicals are the only suppliers of Brucella vaccines, PPR vaccine tender is small around 12 Cr
2-Tanzania unit - At full capacity utilisation total turnover of around 200 Cr is expected, Hester received commitment worth $14 million from Bill & Melinda Gates Foundation, US and till now In Africa 80% Animal vaccines are imported ( will start by end of 2020 )
3-Poultry vaccines company is having 35% market share and in animal vaccine it’s a small player and company is focusing in this area now .
4-Company signed agreement with Egyptian company for technology transfer where Hester will get technology fee.
So Brucella tender , Tanzania unit (where at full capacity utilisation revenue of 200cr is estimated) and increase geographical presence more focus on animal health and poultry segment will be growth driver ( Capex is almost over )
Hester Bio AR Image
.#Hester bioscience-acquisition of new technology for Brucella vaccine @MarketScientist Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dr Prashant Mishra

Dr Prashant Mishra Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @drprashantmish6

Sep 5, 2023
Study this company -
Valiant Communications Ltd( Some Good Points from recent business updates)Although i consider Valiant name as a high risk investment idea because of my old experience with valiant organics , some similarities between valiant organics and valiant communications are
low promotors holding
Recently promotor sold some shares.
( Disclosure - Its not my original idea )
✍️Valiant has become the 1st Indian company whose make “Phasor Measurement Unit (PMU)” has been re-type test approved with latest technical specifications by the Council Of Scientific And Industrial Research–National Physical Laboratory (CSIR–NPL) Based on this approval, the Company has applied for Proof of Concept (PoC) to the Power Grid Corporation of India Limited. It is important to mention that PMU is a key component of “One Nation, One Grid, One Frequency” concept and smart-grid projects. PMU plays a key role in Grid Automation, Grid Stabilization and Load Management of the Power Grid. Globally, there are very few foreign manufacturers, manufacturing PMUs at present. The PMU opportunity is also of global nature. Being an indigenous manufacturer, Valiant is apparently a beneficiary of all business opportunities that are notably arising in the Indian Public Sector out of the ‘Make in India.
✍️Valiant has successfully partnered in the Indian market with Tejas Networks Limited. Both the Companies are determined to replicate their business synergies at the global level also. In a recently concluded tender at Bhutan Power, Tejas (with Valiant’s partnership) has been declared lowest bidder (L1), for which the final PO is awaited. Valiant has also partnered with Tejas and another Tata’ flagship company, for power utility markets in Australasia for multi-years contracts. Given the global reach of the Tata Group, the management is optimistic about the outcome about such opportunities.
✍️Valiant and Tejas have now partnered for the forthcoming large-scale business opportunities for their products supplies at the State Electricity Boards (SEBs) of Kerela, Tamil Nadu, Telangana and Gujarat. These business opportunities are valued at over ` 100+ crores for Valiant
✍️The management expects to improve its operating profit margins in forthcoming quarters in the light of
: • Expected better product-mix;
• Earlier years supplies are entering in AMC phase now, resulting a top-up revenue for services;
• New cutting-edge technology driven products are being offered.
✍️Target IndustriesImage
Cyber Security business: The Company is expected to receive its maiden government contract in the current
quarter. Our Company has already successfully conducted a Proof of Concept (PoC) trials with India's premier Grid
Operator for a few of its Cyber Security products and these successful trials for early detection and warning systems
of cyber-attacks, ransomware attacks and network intrusion to safeguard their Gird communication systems, will
start to generate business revenue in the coming quarters. This opportunity is of very large scale, both domestically
and internationally, due to the unique cyber-security solutions that our Company offers.
The Government has a heightened focus on Cyber Security for all its departments and with a view of protecting
critical infrastructure and its data. This should translate into induction of our Cyber Security products in the
Government Sector under the ‘Make in India’ and the ‘Atmanirbhar Bharat’, path-breaking initiatives taken by the
Government of India.
Read 5 tweets
Jun 22, 2023
Synergy Green -Why i like this company ( No recommendation )
1- Policy change in wind energy sector. Read this

2- Bullish wind energy sector ,read this

3-capacity addition-
4-Clients.



Image
Image
5- Raw Material Prices are now stabilized , so i feel with increase in capacity and stable raw material price now margins should be better. Image
Read Investor PPT from Inox wind- Favorable macro environment for wind Sector. Image
Read 6 tweets
Jun 9, 2023
Ami Organics Concall ( Only imp points)
✍️ our business model is designed in such a way that the revival of the Chinese chemical industry has a minimum to no bearing on us.
✍️On the demand side, we were witnessing gradual upswing in the demand in H2 FY '23. And I believe the revival will continue in H1 FY '24
✍️Electrolyte additives- we have received approval from 6 customers worldwide. We have also received plant-scale trial commercial orders of few metric tons. And we are also expecting a bigger commercial order during the current quarter.
we have developed 2 more products in this segment. One of them is liquid electrolyte additive to increase electrocapacity of the Lithium-Ion batteries and one more additive for solid-state battery
✍️we have been able to expand the scope of our contract with Fermion, and we have added a couple of high value intermediates for the same. This means we will now be doing 3 advanced intermediates for them which increases the value of our contract manyfold.
✍️Fermion contract-( darolutamide, Nubeqa )that is a long-term contract, and it will start supplying from Q3 of FY '24. The full capacity supply will be starting FY '25. Because it is a pharma business, and it takes some time for registrations in 180 countries worldwide. So, in Q3 and Q4, it will be giving us a sizable revenue. But from FY '25, it will be giving us a full revenue, And in that contract only, we have 3 more products, and all 3 products are additional to the contract. So that will also help us to grow more in terms of numbers in the upcoming years.
✍️This product is growing unexpectedly to 200 or 300x a year. Whatever they expected in 2026, they already closed in 2023. So, it's going very fast. And the basic API manufacturing plant in Fermion is fully utilized and the intermediate which they are trying to source from us, they are currently making it in-house. They don't have any source other than us.
✍️ Baba Fine Chemicals acquisition - we are gaining entry into a very high entry barrier semiconductor industry and its products main application in photo resistance chemical in semiconductor industries and they are making very high purity chemicals, And going forward the market is more than $2 million in photo resistance chemicals,It will definitely grow more than 3x to 4x in a year,Baba Fine Chem is currently manufacturing and delivering, is exclusively for one customer. But there are more than 40 products, which are already developed and the samples of which can go to the world. Apart from U.S., other countries like Japan, Korea, etc, we have started promoting this product in those countries also.
✍️Export for the year was at 59%, whereas domestic business was at 41%.
✍️ balance sheet, we have a net debt-free balance sheet with cash and cash equivalent of around INR59 crores
✍️We are targeting this year, that the specialty chemicals segment will grow around 25% to 30% against our normal growth of 22% to 25% of our pharma segment, developed some molecule in sp chemicals with versatile applications, including electronic donor, polymer industry as well as some paint industry additive, UV Absorber, as well as some electronic industry. So, cumulatively once it is all in, it will bring a lot of large volume and large value.
✍️Capex INR200 crores plus next year.

✍️Anticoagulant Basket-Apixaban and rivaroxaban is a growth driver for us for the next 2 years because it's going to be launched. And our generic player worldwide more than 26 customers in apixaban. They are all ready to launch. And also, they won some litigation in U.K. against the originators, so that will help us to start moving very fast. In rivaroxaban, the originator has qualified us, and they started placing order in Q4 FY '23. So now we are supplying to originator as well the rivaroxaban. So, it's a very good growth driver for us in the anticoagulant segment.For Edoxaban three customers in Japan qualified Us.
✍️Ankleshwar facility is upcoming facility which will be ready by December '24 operationally. So that will come with a very huge volume, 4x volume than our unit 1 in Surat. So that will be definitely help us with our FY '24, FY '25 & FY '26 growth of pharma.( Asset turnover Normally 3 but we have high value products.)
✍️Currently, on an average basis, considering sales as a base, our working capital cycle is 108 days. And I try to bring this at 100 days. So, we are continuously working on it
✍️The advantage for Ami Organics or, say, for Indian manufacturer, is that the U.S. and other European countries have stopped buying any battery cells or anything which is generated from China. So that is an added advantage that any manufacturer based outside of China will need to have a raw material from outside China. So that is helping us to push ourselves in a faster mode of getting the orders and all.
✍️Normally, our product basket is well distributed and none of the basket is more than 15%
Ami organics
Ami organics - Image
Read 5 tweets
May 11, 2023
See my f2f with @vivbajaj at 71 min how i identified John cockrail one year back which is now near to all time high , there is now substitute for reading and hardwork .
twitter.com/i/web/status/1…
John Cockerill- Decarbonisation of steel Image
Decarbonising Steel Production pib.gov.in/PressReleasePa…
Read 6 tweets
Mar 18, 2023
Read about ELIN Electronics. 1drv.ms/w/s!AhKBGZ1SnP…
ELIN ELECTRONICS Image
Image
Read 8 tweets
Mar 3, 2023
Sealmatic india -
✍️Manufacturer of Mechanical seal for
• Pumps
• Compressors
• Rotary Applications
• Seal Supply System Components
Sealmatic designs and manufactures mechanical seals and associated products, sealing support systems mainly for the oil & gas,
refinery, petrochemical, chemical, pharmaceutical, fertilizer, power, mining, pulp & paper, aerospace, marine and many more industrial applications.
✍️With a wide range of products and services, Sealmatic has solutions for every sealing requirement – such as Pusher Seals, Standard Cartridge Seals, Elastomer Bellows Seals, Metal Bellows Seals, Engineered Seals, Split Seals, Gas-Lubricated Seals and many more.
Read 31 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(